New drug trial offers hope for painful skin condition

NCT ID NCT06603077

Ongoing Disease control Sponsor: Avalo Therapeutics, Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing whether an investigational drug called AVTX-009 can reduce painful skin lesions in people with moderate to severe hidradenitis suppurativa (HS). About 250 participants will receive either AVTX-009 or a placebo for 16 weeks to see which is more effective at clearing lesions and reducing pain. The main goal is to see if the drug helps at least 75% of lesions clear up without causing significant side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Clinical Site 1001

Boston, Massachusetts, 02215, United States
Clinical Site 1002

Coral Gables, Florida, 33134, United States
Clinical Site 1003

Portsmouth, New Hampshire, 03801, United States
Clinical Site 1004

Philadelphia, Pennsylvania, 19103, United States
Clinical Site 1005

Greenville, South Carolina, 29615, United States
Clinical Site 1007

Fort Gratiot, Michigan, 48059, United States
Clinical Site 1008

Savannah, Georgia, 31419, United States
Clinical Site 1009

Sacramento, California, 95815, United States
Clinical Site 1010

Cleveland, Ohio, 44106, United States
Clinical Site 1011

Washington D.C., District of Columbia, 20010, United States
Clinical Site 1012

Arlington, Texas, 76011, United States
Clinical Site 1013

Tampa, Florida, 33613, United States
Clinical Site 1014

Chicago, Illinois, 60640, United States
Clinical Site 1015

Maitland, Florida, 32751, United States
Clinical Site 1016

New York, New York, 10003, United States
Clinical Site 1017

Dublin, Ohio, 43016, United States
Clinical Site 1018

Johnston, Rhode Island, 02919, United States
Clinical Site 1019

Pomona, California, 91767, United States
Clinical Site 1020

Cincinnati, Ohio, 45219, United States
Clinical Site 1022

Scottsdale, Arizona, 85260, United States
Clinical Site 1023

The Bronx, New York, 10467, United States
Clinical Site 1024

Murray, Kentucky, 42071, United States
Clinical Site 1025

Providence, Rhode Island, 02903, United States
Clinical Site 1026

Tucson, Arizona, 85704, United States
Clinical Site 1027

North Miami Beach, Florida, 33162-4708, United States
Clinical Site 1028

West Lafayette, Indiana, 47906, United States
Clinical Site 1029

Boca Raton, Florida, 33486, United States
Clinical Site 1030

Detroit, Michigan, 48201, United States
Clinical Site 1031

Bowling Green, Kentucky, 42104, United States
Clinical Site 1032

Northridge, California, 91325, United States
Clinical Site 1034

Santa Monica, California, 90024, United States
Clinical Site 1035

Pittsburgh, Pennsylvania, 15213, United States
Clinical Site 1036

Brooklyn, New York, 10023, United States
Clinical Site 1037

Scottsdale, Arizona, 85260, United States
Clinical Site 1041

Oakland, Michigan, 48328, United States
Clinical Site 1042

Boston, Massachusetts, 02115-5804, United States
Clinical Site 1101

Saskatoon, Saskatchewan, S7K 2C1, Canada
Clinical Site 1103

Barrie, Ontario, L4M 7G1, Canada
Clinical Site 1104

Hamilton, Ontario, L8L 3C3, Canada
Clinical Site 1105

Edmonton, Alberta, T5K 1X3, Canada
Clinical Site 1106

Toronto, Ontario, M2N 3A6, Canada
Clinical Site 1107

London, Ontario, N6A 2C2, Canada
Clinical Site 1108

Edmonton, Alberta, T6W 4V4, Canada
Clinical Site 1110

Montreal, Quebec, H1Y 3L1, Canada
Clinical Site 1111

Québec, G1W 4R4, Canada
Clinical Site 1201

Westmead, New South Wales, 2145, Australia
Clinical Site 1202

Carlton, Victoria, 3053, Australia
Clinical Site 1203

Darlinghurst, New South Wales, 2010, Australia
Clinical Site 1204

Woolloongabba, Queensland, 4102, Australia
Clinical Site 1301

Pleven, 5800, Bulgaria
Clinical Site 1302

Lovech, 5500, Bulgaria
Clinical Site 1303

Sofia, Sofia-Grad, 1463, Bulgaria
Clinical Site 1304

Stara Zagora, 6003, Bulgaria
Clinical Site 1401

Prague, Prague, 100 34, Czechia
Clinical Site 1402

Prague, Prague, 150 06, Czechia
Clinical Site 1501

Rouen, Seine-Maritime, 76031, France
Clinical Site 1502

Lyon, Rhône, 69003, France
Clinical Site 1503

Antony, Hauts-de-Seine, 92160, France
Clinical Site 1504

Paris, Île-de-France Region, 75010, France
Clinical Site 1505

Amiens, Picardie, 80054, France
Clinical Site 1601

Bochum, North Rhine-Westphalia, 44791, Germany
Clinical Site 1602

Münster, North Rhine-Westphalia, 48149, Germany
Clinical Site 1604

Frankfurt am Main, Hesse, 60590, Germany
Clinical Site 1605

Dresden, Saxony, 01307, Germany
Clinical Site 1606

Erlangen, Bavaria, 91054, Germany
Clinical Site 1701

Warszawa, Pomeranian Voivodeship, 02-507, Poland
Clinical Site 1702

Wroclaw, Kuyavian-Pomeranian Voivodeship, 51-685, Poland
Clinical Site 1703

Bialystok, Podlaskie Voivodeship, 15-453, Poland
Clinical Site 1704

Ossy, Silesian Voivodeship, 42-624, Poland
Clinical Site 1705

Warszawa, Pomeranian Voivodeship, 02-962, Poland
Clinical Site 1706

Wroclaw, Lower Silesian Voivodeship, 50-566, Poland
Clinical Site 1801

Manises, Valencia, 46940, Spain
Clinical Site 1802

Granada, 18012, Spain
Clinical Site 1803

Madrid, 28034, Spain
Clinical Site 1804

Seville, 41009, Spain
Clinical Site 1901

Torrette, Ancona, 60126, Italy
Clinical Site 1902

Ferrara, 44124, Italy
Clinical Site 1903

Rozzano, Milano, 20089, Italy
Clinical Site 1904

Roma, 168, Italy
Clinical Site 1906

Pisa, 56126, Italy
Clinical Site 1907

Roma, 00144, Italy
Clinical Site 1908

Milan, 20122, Italy
Clinical Site 2001

Gaziantep, 27310, Turkey (Türkiye)
Clinical Site 2002

Samsun, 55270, Turkey (Türkiye)
Clinical Site 2101

Athens, Attica, 16121, Greece
Clinical Site 2102

Efkarpia, Thessaloniki, 56429, Greece
Clinical Site 2103

Athens, Attica, 124 62, Greece
Clinical Site 2201

Trnava, Trnava Region, 917 75, Slovakia
Clinical Site 2202

Svidník, Presov, 089 01, Slovakia

Conditions

Explore the condition pages connected to this study.

HIDRADENITIS SUPPURATIVA